Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Medical Center Alkmaar |
---|---|
Information provided by: | Medical Center Alkmaar |
ClinicalTrials.gov Identifier: | NCT00261534 |
The purpose of this study is to examine the degree of fatigue in patients receiving chemotherapy. Special interest goes out to the course of fatigue throughout five treatments and the actions taken by patients to reduce this fatigue.The correlation between fatigue and haemoglobin will also be subject of study.
Condition |
---|
Cancer Fatigue |
Study Type: | Observational |
Study Design: | Natural History, Longitudinal, Defined Population, Prospective Study |
Official Title: | Outcomes Research on the Course of Cancer Related Fatigue Throughout Five Chemotherapy Treatments |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Netherlands, Noord-Holland | |
Medical Centre Alkmaar | |
Alkmaar, Noord-Holland, Netherlands, 1815JD |
Study Director: | D. Hilarius, MSc | Medical Centre Alkmaar, Hospital Pharmacy |
Study ID Numbers: | M05-057 |
Study First Received: | December 1, 2005 |
Last Updated: | September 13, 2006 |
ClinicalTrials.gov Identifier: | NCT00261534 |
Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Chemotherapy |
Signs and Symptoms Fatigue |